YOL159C-A Antibody

What is YOL159C-A antibody and what organism does it target?

YOL159C-A Antibody (Code: CSB-PA665569XA01SVG) is a monoclonal antibody that specifically binds to the protein encoded by the YOL159C-A gene in Saccharomyces cerevisiae strain ATCC 204508 / S288c. The target protein has the UniProt ID Q3E769 and is currently annotated as a hypothetical protein with uncharacterized biochemical activity. This antibody demonstrates exclusive reactivity to S. cerevisiae strains and shows no reported cross-reactivity with proteins from non-yeast species. The antibody was developed using hybridoma technology, with mice immunized with the full-length recombinant YOL159C-A protein to generate the specific immune response required for monoclonal antibody production.

What are the key specifications and validation parameters for the YOL159C-A antibody?

The YOL159C-A antibody has been characterized with the following specifications and validation parameters:

This antibody has undergone validation primarily for applications in yeast research, with particular emphasis on protein localization studies and expression analysis. When implementing this antibody in new experimental systems, researchers should conduct preliminary optimization experiments to determine optimal dilutions and conditions for their specific applications.

How can YOL159C-A antibody be optimized for Western blot applications?

For optimal Western blot results with YOL159C-A antibody, researchers should employ a systematic optimization approach similar to those used with other yeast proteins. Begin with standard SDS-PAGE protocols using 10-12% gels when working with the hypothetical YOL159C-A protein (UniProt ID Q3E769).

The following methodology is recommended:

• Sample preparation: Lyse yeast cells using glass bead disruption in buffer containing protease inhibitors. For the hypothetical YOL159C-A protein, use a lysis buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, and a protease inhibitor cocktail.

• Protein separation and transfer: After SDS-PAGE, transfer proteins to a PVDF membrane at 100V for 1 hour or 30V overnight at 4°C.

• Blocking and antibody incubation: Block membranes with 5% non-fat dry milk in TBST (TBS with 0.1% Tween-20) for 1 hour at room temperature. For primary antibody incubation, begin with a 1:1000 dilution of YOL159C-A antibody in blocking buffer, and incubate overnight at 4°C.

• Detection optimization: Perform a titration experiment using 1:500, 1:1000, 1:2000, and 1:5000 dilutions to determine optimal antibody concentration for your specific sample conditions.

• Controls: Always include a negative control from a yeast strain with YOL159C-A deletion and a positive control from wild-type S. cerevisiae strain ATCC 204508 / S288c to confirm specificity.

This methodological approach mirrors established protocols for working with hypothetical yeast proteins and should be adjusted based on experimental outcomes.

What are the recommended protocols for using YOL159C-A antibody in immunofluorescence studies?

For immunofluorescence studies using YOL159C-A antibody to investigate the subcellular localization of the target protein in S. cerevisiae, the following protocol is recommended:

• Cell fixation: Grow S. cerevisiae to mid-log phase in appropriate media. Fix cells with 4% formaldehyde for 1 hour at room temperature, followed by washing with PBS.

• Cell wall digestion: Treat cells with zymolyase (100 μg/ml) in digestion buffer (1.2 M sorbitol, 0.1 M potassium phosphate, pH 7.5) for 30 minutes at 30°C to create spheroplasts, allowing antibody penetration.

• Permeabilization and blocking: Permeabilize cells with 0.1% Triton X-100 for 10 minutes, then block with 1% BSA in PBS for 1 hour.

• Antibody incubation: Apply YOL159C-A antibody at 1:100 to 1:500 dilution in blocking buffer and incubate overnight at 4°C. After washing, apply a fluorophore-conjugated secondary anti-mouse IgG antibody (1:1000 dilution) for 1 hour at room temperature.

• Co-staining options: For co-localization studies, combine with organelle-specific markers such as DAPI for nucleus, MitoTracker for mitochondria, or antibodies against specific organelle proteins.

• Imaging parameters: Acquire images using confocal microscopy with appropriate filter sets for the secondary antibody fluorophore. Use Z-stack acquisition (0.3-0.5 μm step size) to capture the three-dimensional distribution of the target protein.

This protocol has been adapted from standard yeast immunofluorescence procedures and should be optimized for the specific research question being addressed.

How can YOL159C-A antibody be used in protein interaction studies and what methodological considerations are important?

YOL159C-A antibody can be employed in various protein interaction studies to identify binding partners of the YOL159C-A protein in S. cerevisiae. The following methodological approaches are recommended:

• Co-immunoprecipitation (Co-IP):

  • Lyse yeast cells in a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.5% NP-40, and protease inhibitors.

  • Pre-clear lysate with protein G beads for 1 hour at 4°C.

  • Incubate cleared lysate with YOL159C-A antibody (5-10 μg per 1 mg of protein) overnight at 4°C.

  • Add protein G beads and incubate for 2-4 hours at 4°C.

  • Wash beads extensively and elute bound proteins.

  • Analyze by SDS-PAGE followed by silver staining or mass spectrometry to identify interacting partners.

• Proximity-dependent biotin identification (BioID):

  • Generate a fusion construct of YOL159C-A with a promiscuous biotin ligase (BirA*).

  • Express the fusion protein in yeast and supply biotin to the growth medium.

  • Harvest cells and isolate biotinylated proteins using streptavidin beads.

  • Identify proximal proteins by mass spectrometry.

  • Validate interactions using YOL159C-A antibody in follow-up Western blot or co-IP experiments.

• Analysis considerations:

  • Always include appropriate controls: IgG control for Co-IP, BirA* only for BioID.

  • Validate key interactions through reciprocal Co-IP or by using tagged versions of identified interacting proteins.

  • Consider that interactions may be condition-dependent; test under various stress conditions relevant to yeast physiology.

These methodological approaches provide complementary information about the protein interaction network of YOL159C-A and can help elucidate its biological function despite its current uncharacterized status.

What are the potential pitfalls in YOL159C-A antibody-based experiments and how can they be addressed?

When working with YOL159C-A antibody, researchers should be aware of several potential experimental pitfalls and implement strategies to address them:

• Specificity concerns:

  • Issue: Given that YOL159C-A targets a hypothetical protein, non-specific binding may be difficult to identify.

  • Solution: Always include a negative control from a YOL159C-A deletion strain. Perform peptide competition assays where the antibody is pre-incubated with excess recombinant YOL159C-A protein before application to samples.

• Signal intensity variability:

  • Issue: Expression levels of hypothetical proteins like YOL159C-A may vary substantially with growth conditions.

  • Solution: Standardize growth conditions rigorously. Consider using quantitative Western blotting with standard curves of recombinant protein for accurate quantification.

• Fixation artifacts in immunofluorescence:

  • Issue: Different fixation methods can alter epitope accessibility and protein localization.

  • Solution: Compare multiple fixation protocols (formaldehyde, methanol, etc.) and validate localization results using a YOL159C-A-GFP fusion protein expressed under native promoter.

• Cross-reactivity in complex samples:

  • Issue: Despite reported specificity, cross-reactivity may occur in certain experimental conditions.

  • Solution: Use appropriate blocking agents. For Western blots, consider using 5% BSA instead of milk if background is high. For immunoprecipitation, include pre-clearing steps with protein G beads.

• Data interpretation challenges:

  • Issue: As YOL159C-A is uncharacterized, interpreting results lacks contextual framework.

  • Solution: Employ parallel approaches such as RNA-seq for transcriptional analysis, proteomic profiling, and bioinformatic prediction of protein function based on sequence/structural features to build a more comprehensive understanding.

These methodological considerations can help researchers design more robust experiments and correctly interpret results when working with antibodies targeting hypothetical proteins like YOL159C-A.

How does YOL159C-A antibody compare with other antibodies targeting hypothetical yeast proteins?

YOL159C-A antibody belongs to a broader category of research tools targeting uncharacterized or hypothetical proteins in Saccharomyces cerevisiae. When comparing with similar antibodies in this category:

Several methodological considerations emerge when comparing these antibodies:

This comparative analysis highlights the need for careful experimental design when working with antibodies targeting hypothetical proteins like YOL159C-A.

What advanced strategies can be used to characterize the function of the YOL159C-A protein using its specific antibody?

Researchers can employ several advanced strategies using YOL159C-A antibody to elucidate the function of this hypothetical protein:

• Stress response profiling:

  • Subject yeast cells to various stressors (oxidative, heat, osmotic, nutrient deprivation)

  • Use YOL159C-A antibody to quantify protein expression changes via Western blot

  • Correlate with mRNA expression data to identify post-transcriptional regulation

  • Monitor potential changes in subcellular localization using immunofluorescence

• Protein complex analysis using Blue Native PAGE:

  • Solubilize yeast membranes using mild detergents

  • Separate native protein complexes using Blue Native PAGE

  • Detect YOL159C-A using the specific antibody to identify associated complexes

  • Excise bands for mass spectrometry analysis to identify complex components

• Conditional depletion combined with antibody detection:

  • Generate an auxin-inducible degron (AID) tagged version of YOL159C-A

  • Trigger rapid protein depletion and monitor cellular consequences

  • Use YOL159C-A antibody to confirm depletion efficiency

  • Perform transcriptomic and proteomic analyses to identify affected pathways

• Proteome-wide interaction mapping:

  • Perform BioID or APEX2 proximity labeling with YOL159C-A fusion

  • Use quantitative mass spectrometry to identify proximal proteins

  • Validate key interactions with YOL159C-A antibody through co-immunoprecipitation

  • Construct an interaction network to predict functional associations

• Post-translational modification analysis:

  • Immunoprecipitate YOL159C-A using the specific antibody

  • Analyze by mass spectrometry for phosphorylation, ubiquitination, or other modifications

  • Generate phospho-specific antibodies if key regulatory sites are identified

  • Correlate modifications with cellular conditions or cell cycle stages

These advanced strategies leverage the specificity of YOL159C-A antibody to systematically characterize the protein's function through complementary approaches, providing insights despite its current uncharacterized status.

How can YOL159C-A antibody research be integrated with machine learning approaches for antibody-antigen binding prediction?

Recent advances in machine learning for antibody-antigen binding prediction offer opportunities to enhance YOL159C-A antibody research:

• Epitope mapping prediction:

  • Apply computational epitope prediction algorithms to identify likely binding sites of YOL159C-A antibody on its target protein

  • Use this information to design experiments that verify the predicted epitopes through mutagenesis or peptide competition assays

  • Recent active learning approaches have shown up to 35% reduction in required experimental data points for accurate binding prediction

• Cross-reactivity assessment:

  • Leverage machine learning models to predict potential cross-reactivity with other yeast proteins

  • This can help identify potential false positives in complex experimental settings

  • Library-on-library approaches can analyze many-to-many relationships between antibodies and antigens to improve specificity

• Affinity optimization:

  • Use machine learning models to predict mutations in the target protein that might affect antibody binding

  • This information can help design controls for experimental validation

  • The Absolut! simulation framework has been used successfully to evaluate out-of-distribution performance for antibody-antigen binding prediction

• Implementation methodology:

  • Begin with small labeled datasets of binding interactions

  • Apply active learning strategies that iteratively expand the labeled dataset

  • The best algorithms have demonstrated acceleration of the learning process by 28 steps compared to random baseline approaches

  • Focus particularly on out-of-distribution prediction scenarios which are most relevant for hypothetical proteins like YOL159C-A

These machine learning integration approaches can help researchers maximize the utility of limited experimental data when working with antibodies targeting hypothetical proteins like YOL159C-A .

What are the considerations for adapting YOL159C-A antibody for advanced microscopy techniques?

Researchers seeking to use YOL159C-A antibody in advanced microscopy applications should consider the following methodological adaptations:

• Super-resolution microscopy (SRM):

  • For STORM/PALM: Conjugate YOL159C-A antibody with photoswitchable fluorophores like Alexa Fluor 647

  • For STED: Use secondary antibodies conjugated with STED-compatible dyes (ATTO 647N, Abberior STAR dyes)

  • Sample preparation: Use thinner sections (70-100 nm) for improved resolution

  • Validation: Compare localization patterns with diffraction-limited approaches to identify potential artifacts

• Live-cell imaging adaptations:

  • Generate recombinant single-chain variable fragments (scFvs) based on YOL159C-A antibody sequence

  • Express intrabodies fused to fluorescent proteins for real-time tracking

  • Alternative approach: Create nanobody equivalents with improved cell penetration

  • Validation: Compare dynamics with fixed-cell immunofluorescence patterns

• Correlative light and electron microscopy (CLEM):

  • Pre-embed labeling: Apply YOL159C-A antibody before resin embedding

  • Post-embed labeling: Apply to ultrathin sections on EM grids

  • Use gold-conjugated secondary antibodies (typically 5-15 nm particles)

  • Control: Include parallel processing of YOL159C-A knockout cells

• Expansion microscopy considerations:

  • Apply YOL159C-A antibody after hydrogel formation and before expansion

  • Use secondary antibodies with minimal hydrogel interaction

  • Optimize expansion protocol for yeast cells (additional cell wall digestion steps)

  • Quantify expansion factor using reference structures

• Quantitative imaging approaches:

  • Implement single-molecule localization protocols

  • Use calibrated fluorescent standards for quantitative comparisons

  • Apply batch correction algorithms when comparing multiple experiments

  • Validate antibody retention during processing steps with control proteins

These methodological considerations address the specific challenges of adapting antibodies like YOL159C-A, which target hypothetical proteins, to advanced microscopy techniques while maintaining specificity and reliability of the results.